{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T19:10:18Z","timestamp":1730747418063,"version":"3.28.0"},"reference-count":24,"publisher":"American Society of Consultant Pharmacists","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["sr care pharm"],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> The objective is to evaluate the impact of consultant pharmacist-directed anticoagulation management in the post-acute and long-term care (PALTC) setting.  <jats:bold>Design:<\/jats:bold> Retrospective study.  <jats:bold>Participants:<\/jats:bold> Patients whose clinical\n details were included in the ASCP aggregate data and were older than 65 years of age, admitted to PALTC facility, and had active anticoagulant therapy were included in the study.  <jats:bold>Interventions:<\/jats:bold> Pharmacists enrolled in the ASCP (Quality Improvement Project) and performed\n monthly chart reviews per standard practice. The 30-day post-chart review follow-up data were entered into the ASCP data collection. The research team assessed for consultant pharmacist interventions associated with anticoagulant therapy management.  <jats:bold>Results:<\/jats:bold> Data were collected\n from November 2022 through March 2023, during which 807 charts were assessed. Within the charts reviewed, 274 patients received anticoagulation therapy, of which 173 (63%) were identified as having a medication-related problem concerning anticoagulant use. Two hundred sixteen pharmacist recommendations\n were sent to providers to address the inappropriate anticoagulant therapy. Providers completed modifications to 190 (88%) of the recommendations.  <jats:bold>Conclusion:<\/jats:bold> This study emphasized pharmacist involvement in managing anticoagulant therapy within the PALTC setting and identified\n the need for further investigation of patient specific outcomes.<\/jats:p>","DOI":"10.4140\/tcp.n.2024.382","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T08:47:04Z","timestamp":1727945224000},"page":"382-392","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the Impact of Consultant Pharmacist-Directed Anticoagulation Management in the Post-Acute and Long-Term Care (PALTC) Setting"],"prefix":"10.4140","volume":"39","author":[{"given":"Alexandra","family":"Schifano","sequence":"first","affiliation":[{"name":"1 University of Cincinnati, James L. Winkle College of Pharmacy, Cincinnati, Ohio."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Statczar","sequence":"additional","affiliation":[{"name":"1 University of Cincinnati, James L. Winkle College of Pharmacy, Cincinnati, Ohio."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Metzger","sequence":"additional","affiliation":[{"name":"1 University of Cincinnati, James L. Winkle College of Pharmacy, Cincinnati, Ohio."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaron","family":"Stout","sequence":"additional","affiliation":[{"name":"5 American Society of Consultant Pharmacists, Alexandria, Virginia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Clark","sequence":"additional","affiliation":[{"name":"5 American Society of Consultant Pharmacists, Alexandria, Virginia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casondra","family":"Seibert","sequence":"additional","affiliation":[{"name":"1 University of Cincinnati, James L. Winkle College of Pharmacy, Cincinnati, Ohio."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","reference":[{"volume-title":"Pharmaceutical care practice: the patient-centered approach to medication management","year":"2012","key":"ref1"},{"issue":"13","key":"ref2","doi-asserted-by":"crossref","first-page":"e017559","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","year":"2020 Jul 7","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/phar.1244","article-title":"Role of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism","volume":"33","year":"2013 Jun","journal-title":"Pharmacotherapy"},{"journal-title":"US Department of Health and Human Services Office of Inspector General","article-title":"Adverse events in long-term-care hospitals: National incidence among medicare beneficiaries","year":"2018","key":"ref4"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1055\/s-0038-1660436","article-title":"Venous thromboembolism (VTE) incidence and VTE-associated survival among Olmsted county residents of local nursing homes","volume":"118","year":"2018 Jul","journal-title":"Thromb Haemost"},{"journal-title":"CHEST guidelines: Pulmonary vascular guidelines and expert panel reports","year":"2023","key":"ref6"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s11606-020-05777-3","article-title":"Comparative safety and effectiveness of direct-acting oral anticoagulants versus warfarin: a national cohort study of nursing home residents","volume":"35","year":"2020 Aug","journal-title":"J Gen Intern Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.thromres.2023.03.007","article-title":"Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: a narrative review","volume":"231","year":"2023","journal-title":"Thromb Res"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/bcp.14127","article-title":"Impact of direct oral anticoagulant off\u2010label doses on clinical outcomes of atrial fibrillation patients: a systematic review","volume":"86","year":"2020","journal-title":"Bri Clin Pharmacol"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/14779072.2021.2013816","article-title":"Off-label direct oral anticoagulants dosing in atrial fibrillation and venous thromboembolism is associated with higher mortality","volume":"19","year":"2021 Dec","journal-title":"Exp Rev Cardiovasc Ther"},{"issue":"22","key":"ref11","doi-asserted-by":"crossref","first-page":"e016949","DOI":"10.1161\/JAHA.120.016949","article-title":"Correcting inappropriate prescribing of direct oral anticoagulants: a population health approach","volume":"9","year":"2020 Nov 17","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"ref12","first-page":"17","article-title":"Adherence to venous thromboprophylaxis guidelines for medical and surgical inpatients of teaching hospitals, Shiraz-Iran","volume":"14","year":"2015","journal-title":"Tanaffos"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11239-017-1487-z","article-title":"Appropriateness of direct oral anticoagulant dosing for venous thromboembolism treatment","volume":"43","year":"2017 May","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1160\/TH16-07-0494","article-title":"Real-life treatment of venous thromboembolism with direct oral anticoagulants: the influence of recommended dosing and regimens","volume":"117","year":"2017 Jan 26","journal-title":"Thromb Haemost"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"e014108","DOI":"10.1161\/JAHA.119.014108","article-title":"Rates of potentially inappropriate dosing of direct-acting oral anticoagulants and associations with geriatric conditions among older patients with atrial fibrillation: The SAGE-AF study","volume":"9","year":"2020 Mar 17","journal-title":"J Am Heart Assoc"},{"issue":"24","key":"ref16","article-title":"Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes","volume":"68","year":"2016","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0897190019828270","article-title":"Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation: insights from the veterans health administration","volume":"33","year":"2020 Oct","journal-title":"J Pharm Pract"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.amjmed.2016.05.041","article-title":"Evaluation of dose-reduced direct oral anticoagulant therapy","volume":"129","year":"2016 Nov","journal-title":"Am J Med"},{"issue":"16","key":"ref19","doi-asserted-by":"crossref","first-page":"e021293","DOI":"10.1161\/JAHA.121.021293","article-title":"Geriatric conditions are associated with decreased anticoagulation use in long-term care residents with atrial fibrillation","volume":"10","year":"2021 Aug 17","journal-title":"J Am Heart Assoc"},{"journal-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","first-page":"CIR0000000000000665","year":"2019 January 28","key":"ref20"},{"journal-title":"State Operations Manual\u2014Centers for Medicare & Medicaid Services","year":"2023","key":"ref21"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3389\/fphar.2018.01220","article-title":"Appropriateness of DOAC prescribing before and during hospital admission and analysis of determinants for inappropriate prescribing","volume":"9","year":"2018 Oct 30","journal-title":"Front Pharmacol"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1060028017726795","article-title":"Assessment of apixaban prescribing patterns for nonvalvular atrial fibrillation in hospitalized patients","volume":"52","year":"2018","journal-title":"Ann Pharmacother"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/1060028017721241","article-title":"Quality of pharmacist-managed anticoagulation therapy in long-term ambulatory settings: a systematic review","volume":"51","year":"2017 Dec","journal-title":"Ann Pharmacother"}],"container-title":["The Senior Care Pharmacist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ascp\/tscp\/2024\/00000039\/00000010\/art00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T18:30:47Z","timestamp":1730745047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.4140\/TCP.n.2024.382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"alternative-id":["2639-9636(20241001)39:10L.382;1-"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2024.382","relation":{},"ISSN":["2639-9636"],"issn-type":[{"type":"print","value":"2639-9636"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}